Cerity Partners’s Genpact G Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.28M Sell
119,216
-110,850
-48% -$3.64M ﹤0.01% 1308
2026
Q1
$8.57M Buy
230,066
+4,891
+2% +$202K 0.01% 772
2025
Q4
$10.5M Buy
225,175
+144,600
+179% +$6.25M 0.02% 619
2025
Q3
$3.38M Buy
80,575
+56,404
+233% +$2.48M 0.01% 1045
2025
Q2
$1.06M Buy
24,171
+12,077
+100% +$547K ﹤0.01% 1488
2025
Q1
$609K Sell
12,094
-3,953
-25% -$196K ﹤0.01% 1657
2024
Q4
$677K Sell
16,047
-1,888
-11% -$79.7K ﹤0.01% 1599
2024
Q3
$703K Buy
17,935
+10,349
+136% +$374K ﹤0.01% 1591
2024
Q2
$244K Buy
+7,586
New +$245K ﹤0.01% 1922
2023
Q1
Sell
-4,699
Closed -$217K 1868
2022
Q4
$217K Buy
+4,699
New +$214K ﹤0.01% 1298
2022
Q1
Sell
-4,037
Closed -$216K 1002
2021
Q4
$216K Buy
+4,037
New +$203K ﹤0.01% 907

Other funds holding G

Cerity Partners's G Position: Q2 2026 in Review

Cerity Partners reduced its Genpact (G) stake by 48% in Q2 2026, selling an estimated $3.64M and leaving 119,216 shares worth $3.28M. The position accounts for ﹤0.01% of the portfolio, ranked #1308.

Cerity Partners first reported a position in G in Q4 2021 and has held it in 11 quarters since. The position peaked at $10.5M in Q4 2025. 444 funds tracked by Wall St. Rank hold G as of Q2 2026.

  • Cerity Partners held 119,216 shares of Genpact worth $3.28M as of Q2 2026.
  • Cerity Partners sold 110,850 Genpact shares in Q2 2026, an estimated $3.64M.
  • Genpact made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #1308 holding.
  • Cerity Partners first reported a position in Genpact in Q4 2021 and has held it in 11 quarters since.
  • Cerity Partners's Genpact position peaked at $10.5M in Q4 2025.
  • 444 funds tracked by Wall St. Rank held Genpact as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.